Diversity of HIV-1 Reservoirs in CD4+ T-cell Subpopulations
Overview
Authors
Affiliations
Purpose Of Review: HIV-1 is able to create lasting reservoirs of virally infected cells that persist life-long and are extremely difficult to eradicate, thus necessitating indefinite antiretroviral therapy. Large numbers of studies suggest that CD4 T cells represent the major, and possibly the only cell type supporting HIV-1 long-term persistence. However, the ability to serve as long-term viral reservoirs may be confined to certain subpopulations of CD4 T cells with specific functional and developmental characteristics that HIV-1 can selectively exploit to propagate long-term viral survival within the host. Identification of CD4 T-cell subtypes that serve as hotspots for viral persistence may be critical for designing strategies to purge the immune system of persisting viral reservoirs.
Recent Findings: Developmentally immature, long-lasting CD4 memory T-cell populations seem to contain the majority of latently HIV-1-infected cells that persist despite antiretroviral therapy in the peripheral blood. Emerging data suggest that functional polarization toward a T helper 17 (Th17), a T follicular helper cell or a regulatory T-cell lineage may also be associated with an increased ability to serve as a viral reservoir site. Atypical T cells such a γδ CD4 T cells or tissue-resident memory CD4 T cells may be predestined to serve as sites for HIV-1 persistence in specific tissues, but will require additional exploration in future studies.
Summary: Recent advances have increased awareness for the profound diversity and complexity of CD4 T-cell subpopulations serving as sites for HIV-1 persistence. Continuous technological and methodological improvements to interrogate viral reservoirs in distinct CD4 T-cell subpopulations may allow to define a more complete landscape of the HIV-1 reservoir composition in different T-cell subpopulations.
Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice.
Jain J, Pham T, Begum S, Romero-Medina M, Bellini N, Li Y iScience. 2025; 27(12):111470.
PMID: 39758987 PMC: 11699618. DOI: 10.1016/j.isci.2024.111470.
Delivering CRISPR to the HIV-1 reservoirs.
Gurrola T, Effah S, Sariyer I, Dampier W, Nonnemacher M, Wigdahl B Front Microbiol. 2024; 15():1393974.
PMID: 38812680 PMC: 11133543. DOI: 10.3389/fmicb.2024.1393974.
Tassaneetrithep B, Phuphuakrat A, Pasomsub E, Bhukhai K, Wongkummool W, Priengprom T Heliyon. 2024; 10(4):e26613.
PMID: 38434025 PMC: 10906414. DOI: 10.1016/j.heliyon.2024.e26613.
Botha J, Byott M, Spyer M, Grant P, Gartner K, Chen W Viruses. 2023; 15(9).
PMID: 37766218 PMC: 10536450. DOI: 10.3390/v15091811.
Evaluation of Archival HIV DNA in Brain and Lymphoid Tissues.
Oliveira M, Pankow A, Vollbrecht T, Kumar N, Cabalero G, Ignacio C J Virol. 2023; 97(6):e0054323.
PMID: 37184401 PMC: 10308944. DOI: 10.1128/jvi.00543-23.